Nanjing, China · Founded 2012 · Privately Held (backing)
Manufacturer of in vitro diagnostic kits designed for early detection of liver cancer in patients with chronic hepatitis B and cirrhosis. SYSDIAGNO is based in Nanjing, China and was founded in 2012. It has raised $14.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$14.8M
Last round
—
Cap table — not yet on record
SYSDIAGNO's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SYSDIAGNO with a free account
·Watch SYSDIAGNO: the Monday email on marks, rounds and moves
